The body sometimes needs a second attempt to tolerate a given dose level, and there is no penalty for taking the escalation more slowly than the standard schedule suggests
[The question] is just whether or not increasing them synthetically is safe or not. There are several well-studied, FDA-approved peptides available today, such as insulin and GLP-1s like Ozempic and Wegovy, but thats just a sliver of the peptide pie
Since semaglutide already impairs the normal B12 absorption pathway, using a form that requires fewer metabolic steps to become active reduces the total burden on an already stressed system
PMID: 11335874
The peptides interaction with other medications appears minimal based on available data
Other commenters offered other ideas, ( including: recommending that we establish a hotline for individuals to report potential HPT noncompliance and following up on those reports within 60 days, recommending that we conduct random audits of hospital websites to assess compliance with the requirements, and suggesting that we require hospitals to publicize on their websites the status of their CMS HPT requirements compliance